There simply aren’t enough new drugs in the pharmaceutical pipeline to keep pace with the evolution of drug-resistant bacteria, the so-called superbugs that are emerging.
There simply aren’t enough new drugs in the pharmaceutical pipeline to keep pace with the evolution of drug-resistant bacteria, the so-called superbugs that are emerging. There is no question that antibiotics have been over prescribed and overused for several decade with a report from the US Centres for Disease Control and Prevention (CDC) estimating that some 20 to 50 percent of antibiotic usage was attributed to unnecessary prescribing for viral infections.1 So, what do we take instead? Read on in the main article.